标题 |
Abstract PD4-07: Subcutaneous administration of the fixed-dose combination of trastuzumab and pertuzumab in combination with chemotherapy in HER2-positive early breast cancer: Primary analysis of the phase III, multicenter, randomized, open-label, two-arm FeDeriCa study
|
网址 | |
DOI |
10.1158/1538-7445.sabcs19-pd4-07
doi
|
其它 |
期刊:Cancer Research 作者:Antoinette R Tan; Seock-Ah Im; Andre Mattar; Ramon Colomer; Daniil Stroyakovskii; et al 出版日期:2020-03-27 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |